Yet, it is also apparent that clones of cancer cells survive this loss of NCLX and coopt the downregulation of NCLX to undergo metabolic reprogramming and gene expression changes that support tumor migration, invasion and metastasis, by initiating a mitochondrial Ca2+/ROS signaling axis to drive HIF1α activation. The gene discussed is HIF1A; the disease is neoplasm.